Nashira Vieira O’REilly Cabral Posada
Research Subjects
Research Interests
Nashira Vieira O’REilly Cabral Posada has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Gleide Célia Virgolino da Silva1 shared publication
- Glécia Virgolino da Silva Luz
Biomedical Engineering Program—PPGGEB, Faculty of Sciences and Technologies in Engineering (FCTE), University of Brasília (UNB), Brasília 70910-900, DF, Brazil
1 shared publication - Graziella Anselmo Joanitti
Laboratory of Biocompounds and Nanobiotechnology, Darcy Ribeiro Campus, University of Brasília, Brasília 70910-900, Brazil
1 shared publication - Ludmilla Pinto Guiotti Cintra Abreu1 shared publication
- Marcella Lemos Brettas Carneiro
Laboratory of Biocompounds and Nanobiotechnology, Darcy Ribeiro Campus, University of Brasília, Brasília 70910-900, Brazil
1 shared publication - Ronaldo Gonçalves Abreu1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- p. 1-20
Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia
Introduction: Cosmetics formulated with nanotechnology (1.0 x 10–⁹ m) have great market potential due to their effectiveness and consumer satisfaction. Objective: To conduct a documentary review of international regulatory requirements related to the safety of cosmetics containing nanomaterials. Method: A systematic documentary analysis was performed using official websites of eight regulatory agencies: the United States, European Union, Canada, Japan, Australia, China, India, and South Korea. The research was structured using the PICOT acronym. Documents were screened based on inclusion and exclusion criteria and evaluated by peer reviewers. Data extraction was conducted using REDCap® software and organized into thematic frameworks. Results: Nine documents were included, with emphasis on those issued by the SCCS (EU), FDA (USA), ICCR, and MHLW (Japan). Regulatory convergence was observed in aspects such as the physicochemical characterization of nanomaterials (including size, morphology, purity, and stability) and the requirement for specific testing related to dermal irritation, inhalation toxicity, genotoxicity, and skin absorption. The analyzed documents highlight that nanomaterials may exhibit physicochemical properties, biological interactions, and toxicological effects distinct from the same ingredients on a conventional scale — with magnetic, optical, structural, electrical, and chemical differences that may impact product performance, safety, and efficacy. Conclusions: There is no international regulatory consensus on mandatory criteria for the useof nanomaterials in cosmetics. Agencies recommend multiple validated tests, applied to different product batches, and emphasize the importance of detailed physicochemical characterization as well as dose–response assessment as essential requirements. The experience of more established jurisdictions can support the advancement of the Brazilian regulatory framework in this emerging field.
- 5 May 2026
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- p. 1-20
Open AccessRevisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia
Introduction: Cosmetics formulated with nanotechnology (1.0 x 10–⁹ m) have great market potential due to their effectiveness and consumer satisfaction. Objective: To conduct a documentary review of international regulatory requirements related to the safety of cosmetics containing nanomaterials. Method: A systematic documentary analysis was performed using official websites of eight regulatory agencies: the United States, European Union, Canada, Japan, Australia, China, India, and South Korea. The research was structured using the PICOT acronym. Documents were screened based on inclusion and exclusion criteria and evaluated by peer reviewers. Data extraction was conducted using REDCap® software and organized into thematic frameworks. Results: Nine documents were included, with emphasis on those issued by the SCCS (EU), FDA (USA), ICCR, and MHLW (Japan). Regulatory convergence was observed in aspects such as the physicochemical characterization of nanomaterials (including size, morphology, purity, and stability) and the requirement for specific testing related to dermal irritation, inhalation toxicity, genotoxicity, and skin absorption. The analyzed documents highlight that nanomaterials may exhibit physicochemical properties, biological interactions, and toxicological effects distinct from the same ingredients on a conventional scale — with magnetic, optical, structural, electrical, and chemical differences that may impact product performance, safety, and efficacy. Conclusions: There is no international regulatory consensus on mandatory criteria for the useof nanomaterials in cosmetics. Agencies recommend multiple validated tests, applied to different product batches, and emphasize the importance of detailed physicochemical characterization as well as dose–response assessment as essential requirements. The experience of more established jurisdictions can support the advancement of the Brazilian regulatory framework in this emerging field.